Psychedelics are big. And they’re possibly about to get a whole lot bigger. If you’re a little Leary of that statement, perhaps our guest today, JR Rahn, CEO of MindMed, may help to change your mind—or at least bring you some new ways of looking at the topic of the therapeutic use of psychedelics.